SoftOx Solutions AS is a Scandinavian medtech company, founded in 2012. After years of research and product development, SoftOx has developed a non-toxic and highly efficient antiseptic technology which eradicates and prevents biofilm infections. Biofilm is found in more than 80 percent of chronic wounds and prevents wound healing.
The SoftOx technology, using acetic acid together with the body’s own disinfector, is developed by SoftOx Solutions AS with the support of leading chemical scientists from CR Competence at University of Lund, Sweden. In 2016, SoftOx Solutions established a partnership with Professor Thomas Bjarnsholt, Chief Surgeon Klaus Kirketerp-Møller, and the University of Copenhagen.
Scientists at University of Copenhagen have since 2007 conducted research on the use of acetic acid against biofilm, and since 2009 used acetic acid in clinical settings. The University of Copenhagen is a leading European research centre on biofilm and chronic wounds. SoftOx Solutions will establish its own scientific unit at the university under leadership of Thomas Bjarnsholt. Klaus Kirketerp-Møller will lead the company’s clinical research at Copenhagen University Hospital.